VA Highlights 17,000-Gene Drug Safety Atlas as Study Ties Metabolic Syndrome to 94% Higher C. diff Risk
Updated
Updated · VA.gov Home | Veterans Affairs · Aug 14
VA Highlights 17,000-Gene Drug Safety Atlas as Study Ties Metabolic Syndrome to 94% Higher C. diff Risk
1 articles · Updated · VA.gov Home | Veterans Affairs · Aug 14
Summary
VA researchers unveiled an interactive genomic atlas built from nearly 17,000 genes that predicts hundreds of known adverse drug reactions and flags potential new drug risks.
Immune-pathway genetic variants stood out in those reactions, suggesting extra scrutiny for medicines that act on those pathways and giving clinicians a new tool to improve drug safety.
In a separate VA pain study, 184 veterans who received six 30-minute cognitive behavioral therapy sessions alongside usual care saw faster, lasting reductions in pain interference, with gains still present three months later.
A Tucson VA analysis of almost 4 million patients across 30 countries found metabolic syndrome raised C. diff infection odds by 94%, far above the 14% increase linked to obesity alone and 11% for diabetes alone.
Those findings point to a broader VA research push that links genetics, behavioral treatment and metabolic health to more targeted prevention and care.